Flutamide

Quick links to important sections

Flutamide

Selected form

Treatment option: Carcinoma

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flutamide

Quick Facts

Property Description
Active Ingredient Flutamide
Form Tablets or Capsules (Oral Formulation)
Pharmacological Class Antiandrogen
General Purpose Systemic Androgen Blockade
Origin Synthetic, Nonsteroidal

Flutamide: Classification and Chemical Identity

Flutamide is a powerful, synthetic, nonsteroidal antiandrogen compound that serves as the active pharmaceutical ingredient (API) in its final medicinal form. As an active chemical entity, Flutamide is consistently classified within the antiandrogen pharmacological class because its fundamental function is to counteract the effects of male sex hormones, known as androgens. Its nonsteroidal composition differentiates it from older hormonal treatments, with a specific receptor-binding profile. This substance is entirely synthetic and not derived from natural steroid sources.


Composition and Oral Administration Form

This medicinal product is a single-entity product based exclusively on the active ingredient Flutamide and is presented as a solid oral formulation, typically available in tablets or capsules. The API is combined with inert solid pharmaceutical excipients (such as binders and fillers) for stability and reliable absorption. This composition is designed for the convenient oral route of administration, allowing the drug to enter the systemic circulation through swallowing, initiating its therapeutic action throughout the body.


General Purpose of Androgen Blockade

The general purpose of Flutamide is to achieve systemic androgen blockade by interfering with how male hormones signal within the body's tissues. It works by acting as an androgen receptor antagonist, preventing androgens from connecting to and activating specific cell receptors. Flutamide is designed to inhibit androgen uptake and/or nuclear binding in target tissues. This antiandrogenic effect is clinically recognized for managing conditions whose progression is dependent on or stimulated by male hormones.

What side effects are possible with Flutamide?

Possible Side Effects and Safety Information

The safety profile of Flutamide, as documented in regulatory labeling, is classified based on the frequency and the body system affected. All documented adverse reactions and safety characteristics are derived from official government health authority sources.

Frequency-Classified Adverse Reactions

The most frequently reported side effects in regulatory documents are classified as Very Common (ge 1/10) and include hot flushes, gynecomastia (breast swelling or tenderness), decreased libido, impotence, and diarrhea. Adverse reactions documented as Common (ge 1/100 to < 1/10) include hepatitis and transient abnormal liver function tests. Rare to Very Rare events include jaundice, anemia, leukopenia, and neoplasm of the male breast.

Serious Safety Concerns and Systemic Effects

A critical, officially documented safety concern is the potential for severe hepatotoxicity, which includes the risk of fatal hepatic failure, liver cell necrosis, and cholestatic jaundice. This risk is often reported within the initial three months of treatment, leading to the mandatory requirement for frequent liver function monitoring during therapy. Hematological events, such as methemoglobinemia and hemolytic anemia, are also documented as serious, rare risks.

System-Organ Class (SOC) Examples of Officially Listed Effects
Hepatobiliary Disorders Liver cell necrosis, Hepatic failure, Jaundice
Reproductive/Endocrine Gynecomastia, Decreased libido, Impotence
Blood/Lymphatic Anemia, Leukopenia, Methemoglobinemia

Population-Specific Safety Constraints

Official labeling defines specific constraints, including the absolute contraindication for use in women, particularly those who are or may become pregnant, due to the documented risk of embryo-fetal toxicity. Caution is also advised in patients with pre-existing severe hepatic disease or specific blood disorders.

Overdose and Emergency Response

Flutamide Overdose and when to seek help

The official regulatory documentation for Flutamide defines the overdose profile primarily by its potential for severe systemic toxicity. The established acute toxic dose in humans has not been determined.


Documented Overdose Manifestations and Risks

Risk Category Key Regulatory Finding
Severe Outcome Risk of acute liver injury (hepatotoxicity), officially documented as having a potentially fatal outcome following overexposure.
Hematologic Effect Potential for methemoglobinemia and associated cyanosis, which poses a risk of tissue hypoxia.
Gastrointestinal Effects Reports include nausea and vomiting; animal studies also noted anorexia and sedation.

Emergency Actions Mandated by Regulators

In the event of a suspected overdose, immediate medical attention is required. Regulatory authorities explicitly mandate that the patient or caregiver contact a Poison Control Center or emergency medical services immediately.

Since no specific antidote is known for Flutamide, management is strictly limited to supportive and symptomatic treatment. This requires frequent monitoring of vital signs and close observation in a hospital setting. Due to the drug being highly protein bound, official documentation states that blood dialysis may not be of any use as a treatment measure. Management procedures may include considering gastric lavage or the administration of activated charcoal.

Therapeutic Uses of Flutamide

Flutamide is an antiandrogen medication that is considered relevant in conditions presenting with acute episodes. It is applied in addressing symptoms related to systemic imbalance to address the symptomatic burden associated with conditions where functional stability becomes affected. This medication is applied in addressing acute or episodic changes, particularly when symptoms intensify in contexts involving heightened systemic burden.

Flutamide may be part of symptomatic management alongside an LHRH agonist, and this approach is considered relevant for easing systemic or localized discomfort. This supports general well-being during symptomatic phases. It is commonly used across conditions presenting with acute episodes and recurrent or episodic manifestations. Flutamide is applied in addressing symptom clusters, as it is used for managing the temporary increase in symptoms, such as those that may occur when an LHRH agonist is first initiated. The treatment provides support that helps ease the overall symptom burden associated with the condition. It may assist with maintaining functional stability and may help patients cope more steadily with symptom fluctuations during periods of acute physiological activity.


Quick Fact: Supports management of symptoms related to heightened physiological activity

Regulatory References

  1. Health Canada Product Monograph on Flutamide

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Flutamide — Official Regulatory Information

Regulatory documentation establishes strict eligibility rules for Flutamide use, defining populations who are permitted, restricted, or absolutely prohibited from taking the medication.


Eligibility Scope

Classification Population Rule
Populations Allowed Adult Male Patients for the treatment of advanced prostate carcinoma.
Absolute Contraindications Female patients, including those who are pregnant or breastfeeding. Patients with known hypersensitivity to flutamide or any of its components.
Severe Hepatic Restriction Contraindicated in patients with severe hepatic impairment (liver dysfunction) or a history of drug-associated hepatotoxicity.

Age and Conditional Use

Classification Rule
Age-Related Rule Contraindicated in children and adolescents; safety and effectiveness have not been established in pediatric patients.
Conditional Use Use requires caution in patients with impaired renal function (moderate to severe) or certain cardiovascular conditions.

The eligibility profile strictly mandates that Flutamide is intended only for the adult male population and requires exclusion of females, pediatric patients, and individuals with specific severe health conditions, particularly related to liver function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes officially documented interactions for Flutamide, based strictly on regulatory prescribing information.

Documented Drug-Drug Interactions

Interacting Substance/Class Official Interaction/Effect Regulatory Requirement
Oral Anticoagulants (e.g., Warfarin) Increased prothrombin time (enhanced anticoagulant effect) reported. Requires close monitoring of prothrombin time and possible anticoagulant dose adjustment.
Theophylline Increased Theophylline plasma concentrations reported. Due to shared metabolic pathway (CYP 1A2) involvement.
LHRH Agonists No documented influence on Flutamide pharmacokinetics. Considered to have no significant interaction.

Other Documented Interactions and Constraints

Flutamide is contraindicated in patients with pre-existing severe hepatic impairment, a constraint based on the potential interaction with liver function. Official regulatory documents advise that patients with pre-existing hepatic dysfunction or impaired renal function should use Flutamide with caution.

Regarding other substances, consuming alcohol may worsen the adverse effect of facial flushing associated with Flutamide treatment. Importantly, official regulatory sources confirm that no interactions have been established with food or herbal products.

Mechanism of Action

Flutamide functions as a non-steroidal antiandrogen (NSAA). It is a prodrug that is rapidly metabolized into its primary active compound, hydroxyflutamide. This metabolite acts by competing with endogenous androgens for binding to the androgen receptor (AR), the principal biological target, located within the cytoplasm of target cells.

This competitive binding prevents the androgen-AR complex from undergoing the necessary conformational change and subsequent dimerization. This antagonistic action inhibits the activated AR complex from translocating from the cytoplasm into the cell nucleus. By blocking nuclear translocation, Flutamide ensures the AR cannot bind to the Androgen Response Elements (AREs) on DNA. This mechanistic cascade results in the reduction of transcription and, consequently, the lowered expression of androgen-dependent genes and proteins, thereby modulating the overall system-level effect of androgenic stimulation.

Dosage and Administration Information

Flutamide is an oral antiandrogen typically presented as tablets or capsules for systemic administration. The standard administration regimen for adults involves a total daily dose of 750 mg, which is achieved by taking a 250 mg dose three times per day. These doses are usually spaced at approximately 8-hour intervals to maintain consistent systemic exposure to the drug. The medication may be administered with or without food, or may be taken after meals.

Its use is procedurally linked to co-therapies. When administered alongside a LHRH agonist, the medication is initiated at least three days prior to the LHRH agonist to manage the initial physiological response. In the context of radiation therapy, administration may commence up to eight weeks before the start of radiation and continues throughout the treatment course. This contextual timing is central to the use protocol.

For specific procedural handling, if a dose is missed, the patient should skip that dose entirely and resume the regular schedule, without attempting to take an extra dose. Furthermore, while some tablets have a score line, this marking is intended only to facilitate breaking for ease of swallowing and is not for dividing the tablet into smaller, equal doses. Use of flutamide in the pediatric population is not established, and no specific dose adjustment is explicitly warranted for older adults or in renal impairment.

Recent Clinical Evidence

Research evidence / Overview of studies for Flutamide


Evidence for use in Advanced Prostate Cancer

Flutamide was studied for use in studies of advanced-stage prostate cancer, where the cancer has spread (metastatic disease). The research mainly examined Flutamide in combination with other hormone therapies, which were studied alongside Flutamide.

The studies explored how this combination therapy affected outcomes related to systemic or functional imbalance associated with the cancer. Research so far indicates that using Flutamide alongside hormone therapy was observed in some studies to be associated with certain patterns in outcomes monitored compared to hormone therapy alone. Findings describe patterns observed in the studies regarding the evolution of patient experience over defined time intervals.

However, the evidence quality varies across studies, and research focused heavily on specific drug combinations and patient groups. Comparative evidence is lacking, and research is still exploring how outcomes relate to those seen in other study settings. Certainty remains low in some areas of the research.


Evidence for use in Locally Advanced Prostate Cancer

This section summarizes studies that evaluated Flutamide as part of an initial or additional treatment plan alongside other treatments, such as radiation, in people with locally advanced prostate cancer, where the cancer is bulky or has not yet spread widely.

This research explored Flutamide in the context of an initial or additional treatment, focusing on outcomes related to systemic or functional imbalance within the body, as well as outcomes reflecting daily functioning or activity level. Studies contribute to the broader evidence landscape by reporting how symptoms evolved when Flutamide was studied in this setting.


Long-term Studies and Follow-up

Research has monitored the use of Flutamide over defined time intervals to understand the results observed over the long term. Studies focusing on long-term use report how symptoms evolved in the observed populations over time.

Despite these efforts, long-term effects are not fully established, and there is limited information for long-term outcomes beyond the initial years for many patients. Follow-up durations were limited in many studies, meaning data are still emerging regarding the results observed over extended periods.


What is Still Uncertain about Flutamide

Research helps show what has been observed so far, but like all medical research, there are always areas where evidence is still developing or where findings are inconsistent. Key areas of uncertainty include the fact that comparative evidence is lacking against many treatments. Furthermore, evidence is limited for long-term use, and research is ongoing to better understand the observed evidence gaps. This evidence highlights what is known — and what is still uncertain.

Frequently Asked Questions (FAQ)

Common questions about Flutamide (FAQ)


Q: What foods or drinks should you avoid while taking Flutamide?

A: Official product information indicates that Flutamide can be taken with or without food. However, consuming alcohol may worsen the adverse effect of facial flushing, a common side effect of this medication. The decision to limit or avoid alcohol due to bothersome flushing should be made with a healthcare provider.


Q: Can Flutamide be taken with blood pressure medication?

A: Regulatory documents do not list interactions with the general class of all blood pressure medications. A documented interaction exists with oral anticoagulants (like Warfarin) that requires a healthcare provider to closely monitor blood clotting ability. Official information also notes that the drug may cause hypertension (high blood pressure) in a small percentage of patients.


Q: How often are blood tests needed while on Flutamide?

A: Liver function monitoring is mandatory due to the potential risk of liver injury. Official prescribing information mandates that a healthcare provider performs liver function tests prior to starting therapy and then typically monthly for the first 4 months of treatment. Periodic testing continues thereafter.


Q: Does Flutamide affect fertility or sperm production?

A: Official information confirms that Flutamide is associated with decreased libido (sex drive) and impotence (erectile dysfunction). Regulatory guidance suggests that for patients on chronic treatment who have not had medical or surgical castration, the possibility of monitoring with periodic sperm counts may be discussed with a healthcare provider.


Q: How does Flutamide work differently than drugs that stop the production of testosterone?

A: Flutamide is classified as a non-steroidal antiandrogen. It works by blocking the androgen receptor on target cells, which prevents testosterone from binding and sending its growth signals. This is a different mechanism than drugs like LHRH agonists, which work by suppressing or stopping the production of testosterone in the body.


Q: Can Flutamide cause weight gain or fluid retention?

A: Yes, regulatory documents note that edema (fluid retention or swelling) was reported in a small percentage of patients during clinical trials. Weight gain has also been reported as an occasional side effect in patients taking this medication.


Q: How long does Flutamide stay in your system after stopping the medication?

A: The active form of Flutamide is a metabolite called hydroxyflutamide. The official pharmacological data indicates that this active metabolite has a plasma half-life of approximately 6 hours. The half-life represents the time it takes for half the concentration of the active drug to be cleared from the blood.


Q: Does taking Flutamide affect your ability to drive or operate machinery?

A: Official product information advises caution because side effects such as fatigue, dizziness, and confusion have been reported. These effects may interfere with the ability to drive safely or operate machinery, and this risk is highlighted in the official product information.


Q: Is it normal to feel more tired than usual when on Flutamide?

A: Yes, fatigue or tiredness (malaise) has been reported as a side effect associated with this medication. Official information notes that persistent tiredness or 'flu-like' symptoms are potential signs of a serious liver problem that should be discussed with a healthcare provider.


Q: Can Flutamide affect mood or cause emotional changes?

A: Official safety information notes that mental or mood changes are possible. These reactions can include feelings of drowsiness, confusion, depression, anxiety, and nervousness, though they are typically reported in a small percentage of patients.


Q: Are generic versions of Flutamide as effective as the brand-name drug?

A: In most countries, regulatory authorities require that generic versions of any drug, including Flutamide, demonstrate bioequivalence to the brand-name product before approval. This means the generic contains the same active ingredient and is considered biologically comparable to the original medication.


Q: What should a patient do if they develop a skin rash while taking Flutamide?

A: A skin rash is documented as a possible sign of a hypersensitivity reaction (allergic reaction). If a rash occurs, particularly if combined with symptoms like itching, hives, or facial swelling, immediate medical attention is necessary, as these may signal a serious allergic response.


Q: Why might a doctor switch a patient from Flutamide to another anti-androgen?

A: Official guidance indicates a doctor may consider switching or discontinuing Flutamide if the patient shows evidence of serious liver injury (such as high liver enzyme levels or jaundice). It may also be stopped if the Prostate Specific Antigen (PSA) levels rise significantly, or if there is objective progression of the underlying disease.


Q: Does Flutamide affect blood sugar levels?

A: Yes, official safety information indicates that a decreased tolerance to glucose (sugar) has been observed in patients on combined androgen blockade. This may lead to the development of diabetes or a loss of blood sugar control in those who already have diabetes. Blood sugar monitoring may be recommended by a healthcare provider during treatment.


Q: Is it normal to have hot flushes when taking Flutamide?

A: Yes, hot flushes are listed in regulatory documents as a Very Common side effect. This means they are experienced by a high number of patients (more than 1 in 10) who take Flutamide.

How should Flutamide be stored and disposed of?

Flutamide Storage and Disposal

Flutamide must be stored at Controlled Room Temperature, typically 20 to 25 C (68 to 77 F). The product requires protection from light, heat, and excessive moisture, and it is explicitly labeled to Keep from freezing.

Packaging and Child Safety

The medication must be dispensed in a tight, light-resistant container that includes a child-resistant closure. It is required to be stored out of the reach of children and pets at all times.

Disposal of Unused Medicine

Official instructions mandate that unused or expired Flutamide must be disposed of according to local requirements. Patients should consult a healthcare professional or utilize a drug take-back program. It is essential not to flush this medicine down the toilet. If take-back options are unavailable, the FDA recommends mixing the pills with an unappealing substance, placing the mixture in a sealed bag, and discarding it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flutamide found in:

A-Z Index: